We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Superfast, Portable COVID-19 Testing Method Detects SARS-CoV-2 Within One Second

By LabMedica International staff writers
Posted on 19 May 2021
Print article
Image: Schematic and photograph of COVID-19 sensor strip and the printed circuit board fabricated to produce a digital sensor output (Photo courtesy of Minghan Xian, Hao Luo, Xinyi Xia, Chaker Fares, Patrick H. Carey IV, Chan-Wen Chiu, Fan Ren, Siang-Sin Shan, Yu-Te Liao, Shu-Min Hsu, Josephine F. Esquivel-Upshaw, Chin-Wei Chang, Jenshan Lin, Steven C. Ghivizzani, and Stephen J. Pearton)
Image: Schematic and photograph of COVID-19 sensor strip and the printed circuit board fabricated to produce a digital sensor output (Photo courtesy of Minghan Xian, Hao Luo, Xinyi Xia, Chaker Fares, Patrick H. Carey IV, Chan-Wen Chiu, Fan Ren, Siang-Sin Shan, Yu-Te Liao, Shu-Min Hsu, Josephine F. Esquivel-Upshaw, Chin-Wei Chang, Jenshan Lin, Steven C. Ghivizzani, and Stephen J. Pearton)
A new superfast, portable COVID-19 testing method detects the SARS-CoV-2 virus much faster than the currently available methods.

Researchers from the University of Florida (Gainesville, FL, USA) and National Chiao Tung University (Hsinchu, Taiwan) have developed a rapid and sensitive testing method for COVID-19 biomarkers. The researchers, who previously demonstrated detection of biomarkers relevant in epidemics and emergencies, such as the Zika virus, heart attacks, and cerebral spinal fluid leaks, leveraged their expertise to develop a sensor system that provides detection within one second, which is far faster than current COVID-19 detection methods.

Detecting the presence of the virus requires amplifying the numbers of the biomarker, such as the copies of viral ribonucleic acid in the common polymerase chain reaction technique for COVID-19 detection, or amplifying the binding signal for a target biomarker. The group’s method amplifies the binding signal for a target biomarker. During measurement, sensor strips are connected to a circuit board via a connector, and a short electrical test signal gets sent between the gold electrode bonded with COVID antibody and another auxiliary electrode. This signal is then returned to the circuit board for analysis. While the system’s sensor strips clearly must be discarded after use, the test circuit board is reusable which means that the cost of testing may be greatly reduced.

“This could alleviate slow COVID-19 testing turnaround time issues,” said Minghan Xian, an author and a chemical engineering doctoral candidate at the University of Florida. “Our biosensor strip is similar to commercially available glucose test strips in shape, with a small microfluidic channel at the tip to introduce our test fluid. Within the microfluidic channel, a few electrodes are exposed to fluid. One is coated with gold, and COVID-relevant antibodies are attached to the gold surface via a chemical method.”

Related Links:
University of Florida
National Chiao Tung University


Gold Member
COVID-19 TEST READER
COVID-19-CHECK-1 EASY READER+
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Amoebiasis Test
ELI.H.A Amoeba

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.